DESCRIPTION
Clopidrogrel is an inhibitor is platelet aggregation.A variety of drugs that inhibit platelet function have been shown to decrease morbid events in people with established atherosclerotic cardiovascular disease as evidenced by storke or transient ischemic attacks, myocardial infarction, or need for bypass or angioplasty. This indicate that platelet participate in the initiation and/or evolution of these events and that inhibiting them can reduce the event rate.

INDICATIONS
Reduction of atherosclerotic events(myocardial infarction, stroke and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease.

DOSAGE & ADMINISTRATION
The recommended dose of Clopidrogrel tablet is 1 tablet daily with or without food. No dosage adjustment is necessary for elderly patients or patients with renal disease.

PREGNANCY
Clopidrogrel tablet should be used during pregnancy only if clearly needed

LACTATION
Because many drugs are excreted in human milk and because of the potential for adverse reactions in nusing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the nursing woman.

PEDIATRIC USE
Safety and effectiveness in the pediatric population have not been established.

INSTRUCTION
Store below 30’C. Protect from heat, light and moisture. Keep out of reach of children.

AVAILABILITY
Res-Q 75mg tablets are available in a blister pack of 10’s.

Manufacturer's
Nabiqasim Industries (PVT) LTD,Pakistan